Date published: 2026-2-2

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZUFSP Inhibitors

Chemical inhibitors of ZUFSP can interfere with its function through various mechanisms that impede cellular processes essential for the protein's activity. Oligomycin A, for instance, inhibits ATP synthase, leading to a depletion of cellular ATP levels, which are vital for energy-dependent enzymes like ZUFSP. Without sufficient ATP, ZUFSP's ability to engage in its enzymatic activities is compromised. Brefeldin A disrupts protein trafficking between the endoplasmic reticulum and Golgi apparatus, which is a crucial pathway for the proper localization and functionality of ZUFSP. Mislocalization caused by Brefeldin A can prevent ZUFSP from accessing its substrates, thereby inhibiting its function. MG132 acts as a proteasome inhibitor, leading to the accumulation of polyubiquitinated proteins, which may sequester ZUFSP away from its intended substrates. Similarly, Lactacystin and Epoxomicin are proteasome inhibitors that could reduce the functionality of ZUFSP by stabilizing proteins that may compete with or act as decoys for ZUFSP's enzymatic processes.

The second paragraph continues to outline the inhibition mechanisms of ZUFSP by selected chemicals. E-64 and Leupeptin inhibit cysteine and serine proteases, respectively. The inhibition of these proteases can result in an accumulation of proteins within the ubiquitin-proteasome pathway, where ZUFSP operates, potentially impeding ZUFSP's ability to interact with its substrates effectively. ALLN, additionally a proteasome inhibitor, could further inhibit the degradation of ubiquitin-protein conjugates, leading to a similar outcome of restricted ZUFSP activity. Chloroquine and 3-Methyladenine disrupt autophagic processes, with the former increasing lysosomal pH and the latter inhibiting autophagosome formation. These disruptions can alter the turnover of proteins that ZUFSP is involved with, leading to its inhibition. Concanamycin A and NH4Cl both act to raise the pH within lysosomes, a condition that can impact the degradation pathways crucial for ZUFSP's functionality. By impeding these degradation pathways, these chemicals can result in an indirect inhibition of ZUFSP. Each chemical, through its unique action on different cellular pathways and structures, can contribute to the inhibition of ZUFSP, thereby impeding its normal function within the cell.

SEE ALSO...

Items 1 to 10 of 11 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Oligomycin A

579-13-5sc-201551
sc-201551A
sc-201551B
sc-201551C
sc-201551D
5 mg
25 mg
100 mg
500 mg
1 g
$179.00
$612.00
$1203.00
$5202.00
$9364.00
26
(1)

Inhibits ATP synthase which leads to a decrease in cellular ATP levels, indirectly inhibiting energy-dependent processes including those required for ZUFSP function.

Brefeldin A

20350-15-6sc-200861C
sc-200861
sc-200861A
sc-200861B
1 mg
5 mg
25 mg
100 mg
$31.00
$53.00
$124.00
$374.00
25
(3)

Disrupts protein trafficking between the endoplasmic reticulum and Golgi apparatus, which can result in the mislocalization and subsequent functional inhibition of ZUFSP, as proper localization is critical for its activity.

MG-132 [Z-Leu- Leu-Leu-CHO]

133407-82-6sc-201270
sc-201270A
sc-201270B
5 mg
25 mg
100 mg
$60.00
$265.00
$1000.00
163
(3)

Proteasome inhibitor that can lead to the accumulation of polyubiquitinated proteins, potentially sequestering ZUFSP and preventing it from accessing its substrates.

E-64

66701-25-5sc-201276
sc-201276A
sc-201276B
5 mg
25 mg
250 mg
$281.00
$947.00
$1574.00
14
(0)

Irreversibly inhibits cysteine proteases; while not a direct inhibitor of ZUFSP, it can limit the availability of ubiquitinated substrates for ZUFSP through inhibition of upstream proteolytic processes.

Leupeptin hemisulfate

103476-89-7sc-295358
sc-295358A
sc-295358D
sc-295358E
sc-295358B
sc-295358C
5 mg
25 mg
50 mg
100 mg
500 mg
10 mg
$73.00
$148.00
$316.00
$499.00
$1427.00
$101.00
19
(3)

Inhibits serine and cysteine proteases which could lead to the accumulation of proteins that compete with or impede ZUFSP’s functional interactions in the ubiquitin-proteasome pathway.

Lactacystin

133343-34-7sc-3575
sc-3575A
200 µg
1 mg
$188.00
$575.00
60
(2)

Another proteasome inhibitor that, by preventing the degradation of ubiquitin-protein conjugates, could lead to reduced functionality of ZUFSP due to substrate unavailability.

Epoxomicin

134381-21-8sc-201298C
sc-201298
sc-201298A
sc-201298B
50 µg
100 µg
250 µg
500 µg
$137.00
$219.00
$449.00
$506.00
19
(2)

Selective proteasome inhibitor that could indirectly inhibit ZUFSP by stabilizing proteins that may act as decoys or competitors for ZUFSP’s enzymatic activity.

Chloroquine

54-05-7sc-507304
250 mg
$69.00
2
(0)

Lysosomotropic agent that increases lysosomal pH and affects autophagy, potentially disrupting ubiquitin-dependent degradation pathways that ZUFSP is involved in.

Autophagy Inhibitor, 3-MA

5142-23-4sc-205596
sc-205596A
50 mg
500 mg
$65.00
$261.00
113
(3)

Inhibits autophagy by blocking autophagosome formation, potentially altering the turnover of proteins that ZUFSP might interact with or regulate.

Concanamycin A

80890-47-7sc-202111
sc-202111A
sc-202111B
sc-202111C
50 µg
200 µg
1 mg
5 mg
$66.00
$167.00
$673.00
$2601.00
109
(2)

V-ATPase inhibitor that suppresses acidification of organelles like lysosomes, affecting the degradation pathways which ZUFSP may be involved with.